Trump administration to impose up to 100% tariffs on unagreed imported drugs.

The Trump administration plans to impose tariffs of up to 100% on imported pharmaceuticals not reaching pricing agreements with the U.S. This measure aims to lower drug prices and encourage domestic manufacturing. Major firms like Pfizer and Eli Lilly have secured exemptions by committing to U.S. production.